Navigation Links
Lung Transplant Hazard May Rise With Obese Recipients, Smoking Donors
Date:3/12/2013

TUESDAY, March 12 (HealthDay News) -- Major risk factors for serious illness and death after a lung transplant include a donor who smoked and a recipient who is obese, according to a new study.

Researchers reviewed the cases of nearly 1,300 people who received lung transplants at 10 U.S. lung-transplant centers over eight years. The study authors evaluated risk factors for severe primary graft dysfunction, a complication that affects up to 25 percent of lung-transplant patients shortly after surgery.

Primary graft dysfunction is the major cause of serious illness and death after lung transplantation.

The study appeared in the March issue of the American Journal of Respiratory and Critical Care Medicine.

The researchers found that lung transplant recipients who were given lungs from smokers had a 5 percent higher risk of developing primary graft dysfunction than those who received lungs from nonsmokers.

But this finding does not mean that smokers should be prohibited from donating lungs, study lead author Dr. Joshua Diamond, an instructor of medicine in the division of pulmonary, allergy and critical care at the University of Pennsylvania's Perelman School of Medicine, said in a school news release.

"Other studies show that overall survival is significantly better than remaining on waiting lists for lung transplantation when donors with a smoking history are part of the donor pool," Diamond said. "Given the limited pool of available lung donors, it's simply not feasible to exclude patients who were previous smokers as potential lung donors."

Compared to normal-weight lung-transplant recipients, the risk of primary graft dysfunction was 7 percent higher in overweight recipients and 11 percent higher in obese recipients.

The researchers also concluded that some previously identified risk factors -- including donor sex, race, age and cause of death -- were not associated with primary graft dysfunction.

Serious primary graft dysfunction usually occurs within three days after lung transplantation. Diamond and his colleagues found that recipients with primary graft dysfunction had a 23 percent risk of dying within 90 days of their transplant, compared with a 5 percent risk for those without the complication.

After one year, the death rate for those who had primary graft dysfunction was 34 percent, compared with 11 percent for those without the condition.

Efforts to better understand, predict and prevent primary graft dysfunction would dramatically improve outcomes for lung-transplant patients, the researchers said.

Although the study tied donors' smoking history and recipients' obesity to a higher risk of lung transplant complications, it did not establish a cause-and-effect relationship.

More information

The U.S. National Heart, Lung, and Blood Institute has more about lung transplantation.

-- Robert Preidt

SOURCE: Perelman School of Medicine, University of Pennsylvania, news release, March 6, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discovery could help to develop drugs for organ transplant and cancer patients
2. Xenotransplantation as a therapy for type 1 diabetes
3. First, Second Kidney Transplants Have Similar Success: Study
4. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
5. Statins prevent cancer in heart transplant recipients
6. U.S. Liver Transplants Declining
7. Study shows antibiotic improves respiratory function in lung transplant patients
8. UCLA launches first face transplantation program in western US
9. Use of Smokers Lungs for Transplant Has Pros, Cons
10. Skin transplant offers new hope for vitiligo patients
11. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Transplant Hazard May Rise With Obese Recipients, Smoking Donors
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare ... Act. Dr. Botelho advocates for the mass media launching of story movements to ... opportunities to share their unfortunate experiences; such a movement can generate the network ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter ... communities in and around the greater Phoenix metropolitan region, is announcing a charity ... The mission of the Homeless Youth Connection is to promote community awareness of ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... and deep lines by smoothing and tightening the skin of the face to ... to address facial aging with very little downtime, Silhouette Instalift is a novel, ...
(Date:12/7/2016)... Ca (PRWEB) , ... December 07, 2016 , ... It ... that funding is with useful, properly analyzed data. The team at Beckman Coulter has ... address the 'need for speed' and the need to operate in a GLP (Good ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 7, 2016  Palatin Technologies, Inc. ("Palatin") (NYSE ... a previously disclosed underwritten public offering of units ... as sole book-running manager, Roth Capital Partners acted ... as co-manager for the offering. "This ... net proceeds, allowing us to continue advancing bremelanotide ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:12/7/2016)... YORK , Dec. 7, 2016 ... report on pulmonary drugs studies the current as ... The stakeholders of this report include companies and ... various pulmonary/respiratory drugs and/or drug-device combinations as well ... This report comprises an elaborate executive summary along ...
Breaking Medicine Technology: